HealthCor Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-98,970
Closed -$9.58M 25
2022
Q3
$9.58M Sell
98,970
-100,330
-50% -$10.7M 1.2% 29
2022
Q2
$21.7M Sell
199,300
-285,440
-59% -$32.4M 2.18% 19
2022
Q1
$57.4M Buy
484,740
+282,030
+139% +$35M 3.83% 6
2021
Q4
$28.5M Buy
+202,710
New +$25.9M 1.55% 24
2020
Q3
Sell
-638,180
Closed -$58.3M 41
2020
Q2
$58.3M Buy
+638,180
New +$57.7M 2.44% 18
2019
Q4
Sell
-756,400
Closed -$63.3M 57
2019
Q3
$63.3M Sell
756,400
-387,760
-34% -$32.9M 2.39% 17
2019
Q2
$96.2M Buy
1,144,160
+1,024,690
+858% +$80.7M 3.73% 9
2019
Q1
$9.55M Buy
+119,470
New +$8.89M 0.39% 42
2018
Q1
Sell
-244,950
Closed -$14M 47
2017
Q4
$14M Buy
+244,950
New +$13.6M 0.46% 32
2016
Q1
Sell
-1,658,540
Closed -$74.5M 40
2015
Q4
$74.5M Sell
1,658,540
-591,460
-26% -$26.1M 4.52% 8
2015
Q3
$90.5M Buy
2,250,000
+2,020,170
+879% +$95.2M 5.09% 5
2015
Q2
$11.3M Buy
+229,830
New +$11M 0.57% 34
2014
Q2
Sell
-99,000
Closed -$3.81M 52
2014
Q1
$3.81M Sell
99,000
-18,300
-16% -$705K 0.23% 50
2013
Q4
$4.5M Buy
+117,300
New +$4.32M 0.27% 46

Other funds holding ABT

HealthCor Management's ABT Position: Q4 2022 in Review

HealthCor Management sold out of Abbott (ABT) in Q4 2022, closing a stake of 98,970 shares — an estimated $9.58M sold.

HealthCor Management first reported a position in ABT in Q4 2013 and held it in 14 quarters. The position peaked at $96.2M in Q2 2019. 2,765 funds tracked by Wall St. Rank hold ABT as of Q4 2022.

  • HealthCor Management reported no remaining Abbott position as of Q4 2022 after selling out during the quarter.
  • HealthCor Management sold 98,970 Abbott shares in Q4 2022, an estimated $9.58M.
  • HealthCor Management first reported a position in Abbott in Q4 2013 and held it in 14 quarters.
  • HealthCor Management's Abbott position peaked at $96.2M in Q2 2019.
  • 2,765 funds tracked by Wall St. Rank held Abbott as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.